NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

The preferred shares used for a BP partnership or Large Fund purchase at a much higher revalued price/MCap might generate the $20 Mil shareholder equity and share price to allow up list to a major exchange. This might cause a break away gap and dramatic run up in the share price as NWBO continues development on both regulatory and manufacturing fronts. This could quickly transform NWBO to a mid cap biotech on a major exchange.
Early investors and new investors buying at these current prices might be in the position as the venture capitalist are to investments successful pre-IPO Biotechs.

The Preferred Shares might be an instrument to allow Parntering and up listing simultaneously. I am venturing on a break away gap and substantially increasing my position for a very long term hold.

The question investors should ask themselves is what is the current fair market value of NWBO accounting for both the risks and potentials if NWBO was trading on a major exchange. NWBO seems extremely undervalued given its potential and how far along it is in manufacturing. This situation can not be sustained indefinitely. It may be that there are large short selling interests that are HFT trading constently buy-cover and then reshorting small portions of their short positions many times a day to suppress the prices to keep their large short positions in the money. They have the tools of HTF algos and a large pool of short shares to dictate the share price.

NWBO needs access to Capital which the short sellers have been restricting that access for years. To gain access to Capital NWBO needs to partner up with a BP together Preferred Stock investment by the BP at a much higher price thereby Gapping the share price and breaking the short sellers rolling short selling grip on the stock. This should be followed very quickly by an up list to a major exchange the allow institutional investors to buy into the newly valued venture.